Improved survival seen with structured program in patients with resected colon cancer who have completed adjuvant chemo ...

Despite its success in advanced melanoma, Bristol Myers Squibb’s fixed-dose PD-1/LAG-3 combo, Opdualag, failed to move the ...

Preclinical and observational studies suggest that exercise may improve cancer outcomes. However, definitive level 1 evidence ...

Adding nivolumab to chemoradiotherapy may reduce recurrence in patients with resected high-risk head and neck cancer, ...

值此契机，丁香园特邀QEELIN 研究的两位 Leading PI —— 中国医学科学院肿瘤医院石远凯教授与中山大学肿瘤防治中心张兰军教授，深度解读该研究开展的初衷与背景、关键数据及临床实践指导意义。

A three year structured exercise programme reduced the relative risk of disease recurrence, new primary cancer, or death by 28% in patients with stage 3 and high risk stage 2 colon cancer, a phase 3 ...

The addition of postsurgical atezolizumab immunotherapy to standard-of-care chemotherapy in patients with stage III deficient ...

A Canadian Cancer Society-funded trial shows a 3-year structured exercise program post-chemotherapy improves survival for colon cancer patients. Involving 889 participants, the trial saw a 28% ...

NANTES, France I June 2, 2025 I OSE Immunotherapeutics SA (ISIN: FR0012127173; Mnemo: OSE), today provided clinical updates on Tedopi®, the “off-the-shelf” ...